The Bovine Lactoferrin Market is being driven by Increasing number of working women and nuclear families
The Bovine Lactoferrin Market is expected to grow at a CAGR of 19.5% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 1284.5 million. The global bovine lactoferrin market is experiencing significant growth due to the expansion of production facilities by both international and regional players. For instance, Royal FrieslandCampina NV's recent announcement of a new bovine lactoferrin production facility in Veghel, Netherlands, will increase their annual capacity from 20 to 80 metric tonnes. This expansion aligns with the growing demand for early life and adult nutrition among infants. Additionally, the new facility adheres to the latest sustainability standards, reflecting the industry's commitment to eco-friendly practices. These developments underscore the ongoing efforts to expand production capacity and drive the growth of the global bovine lactoferrin market throughout the forecast period.
Get more information on Bovine Lactoferrin Market by requesting a sample report
The market is segmented based on
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Market Scope |
|
Report Coverage |
Details |
Page number |
192 |
Base year |
2024 |
Historic period |
2019-2023 |
Forecast period |
2025-2029 |
Growth momentum & CAGR |
Accelerate at a CAGR of 19.5% |
Market growth 2025-2029 |
USD 1284.5 million |
Market structure |
market_structure.ucfirst |
YoY growth 2024-2025(%) |
16.3 |
Key countries |
China, US, Japan, India, South Korea, Germany, UK, Australia, France, and Italy |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
Bovine lactoferrin, an iron-binding protein, is gaining popularity for its various health benefits. With increasing production capacity, this protein offers anticancer effects, making it a valuable functional ingredient. Liposomal lactoferrin, a pure form, is used in healthy diet and living, providing antibacterial effects and immune-stimulating properties. Purity levels are crucial, with genetic engineering technology ensuring high standards. Lactoferrin's antioxidant activity combats viral infections like hepatitis C, and its anti-inflammatory effects aid in treating intestinal ulcers, acute acne, and dermatological conditions. Extraction processes ensure sustainably derived lactoferrin for use in dietary supplements, infant formula, and immune-boosting formulas for working women. Its anti-viral properties and particle engineering make it suitable for personal hygiene and cancer treatment. Natural health enthusiasts embrace bovine lactoferrin as an immune system booster, replacing synthetic chemicals.
The global pharmaceuticals market encompasses entities involved in the research and development (R&D) or manufacturing of various drug categories, including generic, non-generic, and veterinary drugs. According to Technavio, the healthcare market size is determined by the consolidated revenue generated by providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. Factors propelling the expansion of the pharmaceuticals market include the increasing elderly population. By 2050, approximately one-quarter of the US population and Europe's population ratio is projected to be over 60 years old. This demographic shift will fuel demand for healthcare solutions, particularly for conditions prevalent among seniors, such as bacterial infections, pregnancy complications, stomach ulcers, and nutritional deficiencies. Lactoferrin, a glycoprotein with antimicrobial, antiviral, and antioxidant properties, is a promising solution for addressing these health concerns. Its applications span across various sectors, including pharmaceuticals, nutritional products, and veterinary medicine. For instance, lactoferrin's role in preventing bacterial infections and supporting immune function during pregnancy makes it a valuable addition to maternal healthcare products. Similarly, its therapeutic potential in treating stomach ulcers and enhancing nutritional intake for children and seniors positions it as a versatile ingredient in nutraceuticals and dietary supplements. The growing awareness of these benefits, coupled with the rising elderly population, will fuel the demand for lactoferrin-based products, contributing to the growth of the pharmaceuticals market.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted